[HTML] nature.com

[HTML][HTML] Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial

DH Ryan, I Lingvay, J Deanfield, SE Kahn, E Barros… - Nature medicine, 2024 - nature.com
In the SELECT cardiovascular outcomes trial, semaglutide showed a 20% reduction in major
adverse cardiovascular events in 17,604 adults with preexisting cardiovascular disease …
被引用次数：28 相关文章

Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial

DH Ryan, I Lingvay, J Deanfield, SE Kahn… - Nature … - pubmed.ncbi.nlm.nih.gov
In the SELECT cardiovascular outcomes trial, semaglutide showed a 20% reduction in major
adverse cardiovascular events in 17,604 adults with preexisting cardiovascular disease …

Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial

DH Ryan, I Lingvay, J Deanfield, SE Kahn… - Nature …, 2024 - scholars.northwestern.edu
In the SELECT cardiovascular outcomes trial, semaglutide showed a 20% reduction in major
adverse cardiovascular events in 17,604 adults with preexisting cardiovascular disease …

Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial

DH Ryan, I Lingvay, J Deanfield… - Nature …, 2024 - utsouthwestern.elsevierpure.com
In the SELECT cardiovascular outcomes trial, semaglutide showed a 20% reduction in major
adverse cardiovascular events in 17,604 adults with preexisting cardiovascular disease …

Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial.

DH Ryan, I Lingvay, J Deanfield, SE Kahn… - Nature …, 2024 - europepmc.org
In the SELECT cardiovascular outcomes trial, semaglutide showed a 20% reduction in major
adverse cardiovascular events in 17,604 adults with preexisting cardiovascular disease …